Atrial Fibrillation Clinical Trials in Kansas City, Missouri

3 studies are recruiting for atrial fibrillation in Kansas City, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

    REACT-AF is a multicenter prospective, randomized, open-label, blinded endpoint (PROBE design), controlled trial comparing the current Standard Of Care (SOC) of continuous Direct Oral Anticoagulation (DOAC) use versus time-delimited (1 month) DOAC guided by an AF-sensing Smart Watch (AFSW) in parti…

    Stage
    Phase 3
    Ages
    22 to 85
    Site
    University Health Truman Medical Center, Kansas City, Missouri
    Locations
    93 in total
    Run by
    Johns Hopkins University

    See if you can join NCT05836987 on ClinicalTrials.gov

  2. Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

    The primary objective of this study is to evaluate the effectiveness (prevention of thromboembolic events) and safety (major bleeding) of adding oral anticoagulation (OAC) to background antiplatelet therapy in patients who develop new-onset post-operative atrial fibrillation (POAF) after isolated c…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Mid America Health Institute, Kansas City, Missouri
    Locations
    106 in total
    Run by
    Icahn School of Medicine at Mount Sinai

    See if you can join NCT04045665 on ClinicalTrials.gov

  3. Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

    The LockeT II study is a single center, prospective randomized study. It is intended to study the effectiveness of using LockeT device to gain hemostasis after venous procedures as compared to Manual Compression (MC). Approximately 110 patients will be enrolled.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Research Medical Center Clinic, Kansas City, Missouri
    Locations
    6 in total
    Run by
    Kansas City Heart Rhythm Research Foundation

    See if you can join NCT06078735 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.